These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Involvement of recepteur d'origine nantais receptor tyrosine kinase in Epstein-Barr virus-associated nasopharyngeal carcinoma and its metastasis. Chou YC; Chen CL; Yeh TH; Lin SJ; Chen MR; Doong SL; Lu J; Tsai CH Am J Pathol; 2012 Nov; 181(5):1773-81. PubMed ID: 22974584 [TBL] [Abstract][Full Text] [Related]
45. Activation of nuclear factor-kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma. Thornburg NJ; Pathmanathan R; Raab-Traub N Cancer Res; 2003 Dec; 63(23):8293-301. PubMed ID: 14678988 [TBL] [Abstract][Full Text] [Related]
46. Inhibition of the LKB1-AMPK pathway by the Epstein-Barr virus-encoded LMP1 promotes proliferation and transformation of human nasopharyngeal epithelial cells. Lo AK; Lo KW; Ko CW; Young LS; Dawson CW J Pathol; 2013 Jul; 230(3):336-46. PubMed ID: 23592276 [TBL] [Abstract][Full Text] [Related]
47. Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway. Gatto G; Rossi A; Rossi D; Kroening S; Bonatti S; Mallardo M Nucleic Acids Res; 2008 Nov; 36(20):6608-19. PubMed ID: 18940871 [TBL] [Abstract][Full Text] [Related]
48. Emerging roles of small Epstein-Barr virus derived non-coding RNAs in epithelial malignancy. Lung RW; Tong JH; To KF Int J Mol Sci; 2013 Aug; 14(9):17378-409. PubMed ID: 23979421 [TBL] [Abstract][Full Text] [Related]
49. Epstein-Barr virus downregulates microRNA 203 through the oncoprotein latent membrane protein 1: a contribution to increased tumor incidence in epithelial cells. Yu H; Lu J; Zuo L; Yan Q; Yu Z; Li X; Huang J; Zhao L; Tang H; Luo Z; Liao Q; Zeng Z; Zhang J; Li G J Virol; 2012 Mar; 86(6):3088-99. PubMed ID: 22205737 [TBL] [Abstract][Full Text] [Related]
50. Genome-Wide Analysis of 18 Epstein-Barr Viruses Isolated from Primary Nasopharyngeal Carcinoma Biopsy Specimens. Tu C; Zeng Z; Qi P; Li X; Yu Z; Guo C; Xiong F; Xiang B; Zhou M; Gong Z; Liao Q; Yu J; He Y; Zhang W; Li X; Li Y; Li G; Xiong W J Virol; 2017 Sep; 91(17):. PubMed ID: 28637758 [TBL] [Abstract][Full Text] [Related]
51. BART miRNAs: an unimaginable force in the development of nasopharyngeal carcinoma. Wang Y; Guo Z; Shu Y; Zhou H; Wang H; Zhang W Eur J Cancer Prev; 2017 Mar; 26(2):144-150. PubMed ID: 26909566 [TBL] [Abstract][Full Text] [Related]
52. Epstein-Barr virus latent membrane protein 1 induces cellular MicroRNA miR-146a, a modulator of lymphocyte signaling pathways. Cameron JE; Yin Q; Fewell C; Lacey M; McBride J; Wang X; Lin Z; Schaefer BC; Flemington EK J Virol; 2008 Feb; 82(4):1946-58. PubMed ID: 18057241 [TBL] [Abstract][Full Text] [Related]
53. Vesicle-bound EBV-BART13-3p miRNA in circulation distinguishes nasopharyngeal from other head and neck cancer and asymptomatic EBV-infections. Ramayanti O; Verkuijlen SAWM; Novianti P; Scheepbouwer C; Misovic B; Koppers-Lalic D; van Weering J; Beckers L; Adham M; Martorelli D; Middeldorp JM; Pegtel DM Int J Cancer; 2019 May; 144(10):2555-2566. PubMed ID: 30411781 [TBL] [Abstract][Full Text] [Related]
54. EBV-encoded RNA via TLR3 induces inflammation in nasopharyngeal carcinoma. Li Z; Duan Y; Cheng S; Chen Y; Hu Y; Zhang L; He J; Liao Q; Yang L; Sun LQ Oncotarget; 2015 Sep; 6(27):24291-303. PubMed ID: 26172457 [TBL] [Abstract][Full Text] [Related]
55. Down-regulation of EBV-LMP1 radio-sensitizes nasal pharyngeal carcinoma cells via NF-κB regulated ATM expression. Ma X; Yang L; Xiao L; Tang M; Liu L; Li Z; Deng M; Sun L; Cao Y PLoS One; 2011; 6(11):e24647. PubMed ID: 22096476 [TBL] [Abstract][Full Text] [Related]
56. Rediscovery of NF-κB signaling in nasopharyngeal carcinoma: How genetic defects of NF-κB pathway interplay with EBV in driving oncogenesis? Yi M; Cai J; Li J; Chen S; Zeng Z; Peng Q; Ban Y; Zhou Y; Li X; Xiong W; Li G; Xiang B J Cell Physiol; 2018 Aug; 233(8):5537-5549. PubMed ID: 29266238 [TBL] [Abstract][Full Text] [Related]
57. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma. Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574 [TBL] [Abstract][Full Text] [Related]
58. Association of Plasma Epstein-Barr Virus LMP1 and EBER1 with Circulating Tumor Cells and the Metastasis of Nasopharyngeal Carcinoma. Sun L; Wang Y; Shi J; Zhu W; Wang X Pathol Oncol Res; 2020 Jul; 26(3):1893-1901. PubMed ID: 31832991 [TBL] [Abstract][Full Text] [Related]
59. Regulation network and expression profiles of Epstein-Barr virus-encoded microRNAs and their potential target host genes in nasopharyngeal carcinomas. Zeng Z; Huang H; Huang L; Sun M; Yan Q; Song Y; Wei F; Bo H; Gong Z; Zeng Y; Li Q; Zhang W; Li X; Xiang B; Li X; Li Y; Xiong W; Li G Sci China Life Sci; 2014 Mar; 57(3):315-326. PubMed ID: 24532457 [TBL] [Abstract][Full Text] [Related]
60. Detection of Epstein-Barr virus (EBV)-encoded microRNAs in plasma of patients with nasopharyngeal carcinoma. Gao W; Wong TS; Lv KX; Zhang MJ; Tsang RK; Chan JY Head Neck; 2019 Mar; 41(3):780-792. PubMed ID: 30548946 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]